RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Use of Dapagliflozin in the Management of Type 2 Diabetes Mellitus: A Real-World Evidence Study in Indian Patients (FOREFRONT).

Use of Dapagliflozin in the Management of Type 2 Diabetes Mellitus: A Real-World Evidence Study in Indian Patients (FOREFRONT).

Add to Collection
2019 Aug Others V Viswanathan, KP Singh - Diabetes Technology & Therapeutics, 2019 - liebertpub.com

Full Author : ['Viswanathan, Vijay', 'Singh, K P']
Journal Title : Diabetes technology & therapeutics
Chapter : Section3
Journal Year : 2019
Cited by : 13.0

Background: Dapagliflozin is approved in India based on a controlled clinical study. This study included type 2 diabetes mellitus (T2DM) Indian patients to determine effectiveness of dapagliflozin in the real-world setup. Methods: Data were collected retr..... Read More

Keywords : ["type diabetes mellitus", "realworld evidence study", "indian patient forefront", "use", "management", "dapagliflozin"]
PubMed Link : https://www.liebertpub.com/doi/abs/10.1089/dia.2019.0052
Google Scholar Link : https://scholar.google.com/scholar?cites=2804766371979919656&as_sdt=80005&sciodt=0,11&hl=en&num=20